Phenylketonuria cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) (Created page with "__NOTOC__ {{Phenylketonuria}} {{CMG}} {{AE}} ==Overview== ==Cost-effectiveness of Therapy== ==References== {{Reflist|2}} Category:Metabolic disorders Category:Gen...") |
m (Categories) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Phenylketonuria}} | {{Phenylketonuria}} | ||
{{CMG}}; {{AE}} | |||
{{CMG}} {{AE}} | |||
==Overview== | ==Overview== | ||
| Line 10: | Line 8: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category: | [[Category:Endocrinology]] | ||
{{WS}} | |||
{{WH}} | |||
Latest revision as of 13:13, 26 July 2016
|
Phenylketonuria Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Phenylketonuria On the Web |
|
American Roentgen Ray Society Images of Phenylketonuria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: